Return on Assets: An indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Calculated as: Income from Continuing Operations / Total Assets
Pieris Pharmaceuticals, Inc. (PIRS) had Return on Assets of -63.45% for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$42.81M |
|
$-24.54M |
|
-- |
|
$42.81M |
|
$72.57M |
|
$-29.76M |
|
$5.21M |
|
$-24.54M |
|
$-24.54M |
|
$-24.54M |
|
$-24.54M |
|
$-24.54M |
|
$-24.54M |
|
$-29.76M |
|
$-27.85M |
|
1.13M |
|
1.13M |
|
$-21.60 |
|
$-21.60 |
|
| Balance Sheet Financials | |
$38.68M |
|
-- |
|
-- |
|
$38.68M |
|
$11.92M |
|
-- |
|
-- |
|
$11.92M |
|
$26.76M |
|
$26.76M |
|
$26.76M |
|
1.24M |
|
| Cash Flow Statement Financials | |
$-53.82M |
|
$12.00M |
|
$19.80M |
|
$38.63M |
|
$17.40M |
|
$-21.24M |
|
$3.35M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.24 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-69.51% |
|
-69.51% |
|
-65.06% |
|
-57.33% |
|
-57.33% |
|
$-53.99M |
|
-- |
|
-- |
|
-- |
|
1.11 |
|
-- |
|
7.09 |
|
51.49 |
|
-91.72% |
|
-91.72% |
|
|
Return on Assets |
-63.45% |
-91.72% |
|
$21.64 |
|
$-47.96 |
|
$-47.81 |
|